"For the first time, women could have the option of being treated once a year for osteoporosis, instead of having to remember to take a weekly pill," Black said. "Adherence to these weekly and monthly regimens is often a problem, so an annual treatment means patients are far more likely ...
After 12 months, a single infusion significantly reduces turnover of bone and improves bone density in PMO. Zoledronic acid was first approved in 2001 and has been used for the treatment of Paget disease and for selected bone conditions in cancer under the name Zometa.Osteoporosis is an ...
once a year 听听怎么读 英[wʌns ei jə:] 美[wʌns e jɪr] 是什么意思 释义 一年一度; 学习怎么用 权威例句 Once a Year Once a Year Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis...
ObjectivesTo compare effectiveness, associated cost of outcomes and cost-effectiveness of a single annual infusion of zoledronic acid versus current treatment strategies plans for postmenopausal osteoporosis in France.MethodsTwelve simulation-based models were built to investigate three types of fractures: ve...
The drug is a treatment that needs to be taken only once a year. According to Novartis, The EU regulator approved the drug for the treatment of women with post-menopausal osteoporosis.EBSCO_bspWall Street Journal Eastern Edition
Although zoledronic acid was dominated by alendronate, the incremental quality-adjusted life year (QALY) was quite small in extent. Considering the advantage of once-yearly injection of zoledronic acid in persistence, zoledronic acid might be a cost-effective treatment option compared to once-weekly ...
Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis. The efficacy and tolerability of risedronate once-a-week dosing (35 and 50mg) were compared with risedronate daily dosing (5mg) in a 2-year study in women ... S,T,Harris...
Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-t... No tolerability concerns or new safety signals were observed. Conclusions Treatment with IV ibandronate 2mg bimonthly or 3mg quarterly is ef...
comprised of a 52-week main phase followed by a three-year extension period. Two-hundred growth hormone treatment naïve, prepubertal children with growth hormone deficiency were randomly assigned in a 2:...
comprised of a 52-week main phase followed by a three-year extension period. Two-hundred growth hormone treatment naïve, prepubertal children with growth hormone deficiency were randomly assigned in a 2:1...